Requirement and role of C5a in acute lung inflammatory injury in rats

Journal of Clinical Investigation

Volumn 98, Issue 2, 1996, Pages 503-512

  Mulligan, Michael S ^a   Schmid, Elisabeth ^a,b   Beck Schimmer, Beatrice ^a,b   Till, Gerd O ^a   Friedl, Hans P ^b   Brauer, Robert B ^c   Hugli, Tony E ^d   Miyasaka, Masayuki ^e   Warner, Roscoe L ^a   Johnson, Kent J ^a   Ward, Peter A ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^c TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^d SCRIPPS RESEARCH INSTITUTE   (United States)

^e OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

C5a; cobra venom factor; complement; immune complexes; lung injury; neutrophils

Indexed keywords

ALBUMIN I 125; COBROTOXIN; COMPLEMENT COMPONENT C5A; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; MYELOPEROXIDASE; POLYCLONAL ANTIBODY; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL MODEL; ANTIGEN ANTIBODY COMPLEX; ARTICLE; BLOOD VESSEL PERMEABILITY; CONTROLLED STUDY; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; INFLAMMATION; LUNG INJURY; LUNG LAVAGE; NEUTROPHIL; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; RAT;

EID: 9344265768     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI118818     Document Type: Article

References (45)

1. Frank, M.M., and L.F. Fries. 1991. The role of complement in inflammation and phagocytosis. Immunol. Today. 12:322-326.
2. Spath, P.J. 1992. Role of complement in inflammation and bacterial killing. Curr. Stud. Hematol. Blood Transfus. 59:100-145.
3. Cooper, N.R., and G.R. Nemerow. 1985. Complement effector mechanisms in health and disease. J. Invest. Dermatol. 85(Suppl.):395-465.
4. Desai, U., D.L. Kreutzer, H.T. Showell, C.V. Arroyave, and P.A. Ward. 1979. Acute inflammatory pulmonary reactions induced by chemotactic factor. Am. J. Pathol. 96:71-83.
5. Henson, P.M., K.M. McCarthy, and G.L. Larsen. 1979. Complement fragments, pulmonary macrophages and alveolits. Am. J. Pathol. 97:93-105.
6. Larsen, G.L., K.M. McCarthy, R.V. Webster, T. Henson, and P.M. Henson. 1980. A differential effect of C5a and C5a des arg in the induction of pulmonary inflammation. Am. J. Pathol. 100:179-191.
7. Larsen, G.L., B.C. Mitchell, and P.M. Henson. 1981. The pulmonary response of C5 sufficient and deficient mice to immune complexes. Am. Rev. Respir. Dis. 123:434-439.
8. Till, G.O., M.L. Morganroth, R. Kunkel, and P.A. Ward. 1987. Activation of C5 by cobra venom factor is required in neutrophil-mediated lung injury in the rat. Am. J. Pathol. 129:44-53.
9. Tvedten, H.W., G.O. Till, and P.A. Ward. 1985. Mediators of lung injury in mice following systemic activation of complement. Am. J. Pathol. 119:92-100.
10. Hohn, D.C., A.J. Meyers, S.T. Gherini, A. Beckman, R.E. Morkison, and A.M. Chung. 1980. Production of acute pulmonary injury by leukocytes and activated complement. Surgery (St. Louis). 88:48-58.
11. Hosea, S., E. Brown, C. Hammer, and M. Frank. 1980. Role of complement activation in a model of adult respiratory distress syndrome. J. Clin. Invest. 66:375-382.
12. Perkowski, S.Z., A.M. Havill, J.T. Flynn, and M.H. Gee. 1983. Role of intrapulmonary release of eicosanoids and superoxide anion as mediators of pulmonary dysfunction and endothelial injury in sheep with intermittent complement activation. 1983. Circ. Res. 53:574-583.
13. Weisman, H.F., T. Bartow, M.K. Leppo, H.C. Marsh, Jr., G.R. Carson, M.F. Concino, M.P. Boyle, K.H. Roux, M.L. Weisfeldt, and D.T. Fearon. 1990. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science (Wash. DC). 249:146-151.
14. Mulligan, M.S., C.G. Yeh, A.R. Rudolph, and P.A. Ward. 1992. Protective effects of soluble CR1 in complement- and neutrophil-mediated tissue injury. J. Immunol. 148:1479-1485.
15. Cochrane, C.G., H.J. Muller-Eberhard, and B.S. Aikin. 1970. Depletion of plasma complement in vivo by a protein of cobra venom: its effect on various immunologic reactions. J. Immunol. 105:55-69.
16. Johnson, K.J., and P.A. Ward. 1974. Acute immunologic pulmonary alveolitis. J. Clin. Invest. 54:349-357.
17. Till, G.O., K.J. Johnson, R. Kunkel, and P.A. Ward. 1982. Intravascular activation of complement and acute lung injury. Dependency on neutrophils and toxic oxygen metabolites. J. Clin. Invest. 69:1126-1135.
18. Johnson, A.R., T.E. Hugli, and H.J. Muller-Eberhard. 1975. Release of histamine from rat mast cells by the complement peptides C3a and C5a. Immunology. 28:1067.
19. Meuer, S., U. Ecker, U. Hadding, and D. Bitter-Suermann. 1981. Platelet-serotonin release by C3a and C5a: two independent pathways of activation. J. Immunol. 126:1506-1509.
20. Smedegard, G., L. Cui, and T.E. Hugli. 1989. Endotoxin-induced shock in the rat. A role for C5a. Am. J. Pathol. 135:489-497.
21. Foreman, K.E., A.A. Vaporciyan, B.K. Bonish, M.L. Jones, K.J. Johnson, M.M. Glovsky, S.M. Eddy, and P.A. Ward. 1994. C5a-induced expression of P-selectin in endothelial cells. J. Clin. Invest. 94:1147-1155.
22. Kilgore, K.S., J. Shen, B.F. Miller, P.A. Ward, and J.S. Warren. 1995. Enhancement by the complement membrane attack complex of TNF-induced endothelial cell expression of E-selectin and ICAM-1. J. Immunol. 155:1434-1441.
23. Hänsch, G.M., M. Seitz, and M. Betz. 1987. Effect of the late complement component C5b-9 on human monocytes: release of prostanoids, oxygen radicals and of a factor inducing cell proliferation. Int. Arch. Allergy Appl. Immunol. 82:317-320.
24. Pertosa, G., E.A. Tarantino, L. Gesualdo, V. Montinaro, and F.P. Schena. 1993. C5b-9 generation and cytokine production in hemodialyzed patients. Kidney Int. Suppl. 41:221-225.
25. Cotran, R.S., V. Kumar, and S.L. Robins. 1994. The Kidney. In Robbins - The Pathological Basis of Disease. 5th ed. W.B. Saunders Co., Philadelphia. 927-989.
26. Haslam, P.L., P.J. Townsend, and M.A. Branthwaite. 1980. Complement activation during cardiopulmonary bypass. Anaesthesia. 25:22-26.
27. Craddock, P.R., J. Fehr, A.P. Dalmasso, K.L. Brigham, and H.S. Jacob. 1977. Hemodialysis leukopenia: pulmonary vascular leukostasis resulting from complement activation by dialyzes cellophane membranes. J. Clin. Invest. 59: 879-888.
28. Jacob, H.S. 1980. Complement-induced vascular leukostatsis. Its role in tissue injury. Arch. Pathol. Lab. Med. 104:617-620.
29. Mulligan, M.S., A.A. Vaporciyan, M. Miyasaka, T. Tamatani, and P.A. Ward. 1993. Tumor necrosis factor α regulates in vivo intrapulmonary expression of ICAM-1. Am. J. Pathol. 142:1739-1749.
30. Cui, L., D.F. Carney, and T.E. Hugli. 1994. Primary structure and functional characterization of rat C5a: an anaphylatoxin with unusually high potency. Protein Sci. 3:1169-1117.
31. Jones, M.L., and P.A. Ward. 1992. Monocyte chemoattractant protein-1 in a rat model of pulmonary granulomatosis. Lab. Invest. 66:498-503.
32. Leenarts, P.L., R.K. Stad, B.M. Hall, B.J. Van Damme, Y. Vanrenterghem, and M.R. Daha. 1994. Hereditary C6 deficiency in a strain of PVG/c rats. Clin. Exp. Immunol. 97:478-482.
33. Brauer, R.B., W.M. Baldwin, M.R. Daha, S.K. Pruitt, and F. Sanfilippo. 1993. Use of C6-deficient rats to evaluate the mechanism of hyperacute rejection of discordant cardiac xenografts. J. Immunol. 151:7240-7248.
34. Hill, J.H., and P.A. Ward. 1971. The phlogistic role of C3 leukotactic fragments in myocardial infarcts of rats. J. Exp. Med. 133:885-900.
35. McEver, R.P., J.H. Beckstead, K.L. Moore, L. Marshall-Carlson, and D.F. Bainton. 1989. GMP-140, a platelet α-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J. Clin. Invest. 84:92-99.
36. Hattori, R., K.K. Hamilton, R.P. McEver, and P.J. Sims. 1989. Complement proteins C5b-C9 induce secretion of high molecular weight multimers of endothelial von Willebrand factor and translocation of granule membrane protein GMP-140 to the cell surface. J. Biol. Chem. 264:9053-9060.
37. Mulligan, M.S., C.W. Smith, D.C. Anderson, R.F. Todd III, M. Miyasaka, T. Tamatani, T.B. Issekutz, and P.A. Ward. 1993. Role of leukocyte adhesion molecules in complement-induced lung injury. J Immunol. 150:2401-2406.
38. Mulligan, M.S., M.J. Polley, R.J. Bayer, M.F. Nunn, J.C. Paulson, and P.A. Ward. 1992. Neutrophil-dependent acute lung injury: requirement for P-selectin (GMP-140). J. Clin. Invest. 90:1600-1607.
39. Ward, P.A., and M.S. Mulligan. 1995. Role of adherence molecules in lung inflammation. In Physiology and Pathophysiology of Leukocyte Adhesion. D.N. Granger and G.W. Schmid-Schonbein, editors. Oxford University Press, New York. 313-322.
40. Shanley, T.P., H. Schmal, H.P. Friedl, M.L. Jones, and P.A. Ward. 1995. Role of macrophage inflammatory protein-1α (MIP-1α) in acute lung injury in rats. J. Immunol. 154:4793-4802.
41. Mulligan, M.S., G.P. Wilson, R.F. Todd, C.W. Smith, D.C. Anderson, J. Varani, T. Issekutz, M. Miyasaka, T. Tamatani, J.R. Rusche, et al. 1993. Role of β1, β2 integrins and ICAM-1 in lung injury following deposition of IgG and IgA immune complexes. J. Immunol. 150:2407-2417.
42. Rinder, C.S., H.M. Rinder, B.R. Smith, J.C.K. Fitch, M.J. Smith, J.B. Tracey, L.A. Matis, S.P. Squinto, and S.A. Rollins. 1995. Blockade of C5a and C5b-9 generation inhibits leukocyte and platelet activation during extracorporeal circulation. J. Clin. Invest. 96:1564-1572.
43. Ward, P.A., J. Chapitis, M.C. Conroy, and I.H. Lepow. 1973. Generation by bacterial proteinases of leukotactic factors from human serum and C3 and C5. J. Immunol. 110:1003-1009.
44. Stevens, J.H., P. O'Hanley, J.M. Shapiro, F.G. Mihm, P.S. Satoh, J.A. Collins, and T.A. Raffin. 1986. Effects of anti-C5a antibodies on the adult respiratory distress syndrome in septic primates. J. Clin. Invest. 77:1812-1816.
45. Hangen, D.H., J.H. Stevens, P.S. Satoh, E.W. Hall, P.T. O'Hanley, and T.A. Raffin. 1989. Complement levels in septic primates treated with anti-C5a antibodies. J. Surg. Res. 46:195-199.